Nutriband Inc. (NASDAQ:NTRB) to Sell 90% Interest in Pocono Pharmaceutical to EarthVision Bio

ORLANDO, Fla. — December 29, 2025 — Leads & Copy — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has announced an agreement to sell a 90% stake in its subsidiary, Pocono Pharmaceutical, to EarthVision Bio for $5 million USD.

Nutriband Inc. shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition, which is expected to close on Dec 31, 2025.

Earthvision Bio is actively developing and commercializing a line of sustainable products. These products were created by Dr. Gordon Moore, the founder of Intel (NASDAQ: INTC), and Dr. Hans Franke, formerly the board chairman for Chevron Europe. The company’s developments offer a sustainable alternative to plastic, molded fiber, wood, and paper products.

Nutriband Inc. intends to allocate the proceeds from the sale of Pocono Pharma to further the development of AVERSA Fentanyl. This product is designed as an abuse-deterrent opioid patch to combat abuse, misuse, and accidental exposure, and has the potential to reach annual US sales of $80 million to $200 million.

AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, including opioids and stimulant drugs, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.

Nutriband Inc. is focused on developing a portfolio of transdermal pharmaceutical products. Their lead product is an abuse-deterrent fentanyl patch using their AVERSA™ technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Earthvision Bio Contact:
Tina Hoefer
Phone: 213-531-9995
Email: Tina@earthvisionbio.com

Nutriband Inc. Contact:
Phone: 407-377-6695
Email: info@nutriband.com

Source: Nutriband Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.